Literature DB >> 23223229

The Dok-3/Grb2 protein signal module attenuates Lyn kinase-dependent activation of Syk kinase in B cell antigen receptor microclusters.

Marion Lösing1, Ingo Goldbeck, Birgit Manno, Thomas Oellerich, Tim Schnyder, Hanibal Bohnenberger, Björn Stork, Henning Urlaub, Facundo D Batista, Jürgen Wienands, Michael Engelke.   

Abstract

Recruitment of the growth factor receptor-bound protein 2 (Grb2) by the plasma membrane-associated adapter protein downstream of kinase 3 (Dok-3) attenuates signals transduced by the B cell antigen receptor (BCR). Here we describe molecular details of Dok-3/Grb2 signal integration and function, showing that the Lyn-dependent activation of the BCR transducer kinase Syk is attenuated by Dok-3/Grb2 in a site-specific manner. This process is associated with the SH3 domain-dependent translocation of Dok-3/Grb2 complexes into BCR microsignalosomes and augmented phosphorylation of the inhibitory Lyn target SH2 domain-containing inositol 5' phosphatase. Hence, our findings imply that Dok-3/Grb2 modulates the balance between activatory and inhibitory Lyn functions with the aim to adjust BCR signaling efficiency.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23223229      PMCID: PMC3554902          DOI: 10.1074/jbc.M112.406546

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK--functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling.

Authors:  S Hashimoto; A Iwamatsu; M Ishiai; K Okawa; T Yamadori; M Matsushita; Y Baba; T Kishimoto; T Kurosaki; S Tsukada
Journal:  Blood       Date:  1999-10-01       Impact factor: 22.113

2.  Dok-3, a novel adapter molecule involved in the negative regulation of immunoreceptor signaling.

Authors:  S Lemay; D Davidson; S Latour; A Veillette
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

3.  Interaction of SLP adaptors with the SH2 domain of Tec family kinases.

Authors:  Y W Su; Y Zhang; J Schweikert; G A Koretzky; M Reth; J Wienands
Journal:  Eur J Immunol       Date:  1999-11       Impact factor: 5.532

4.  BLNK: molecular scaffolding through 'cis'-mediated organization of signaling proteins.

Authors:  Christopher W Chiu; Mark Dalton; Masamichi Ishiai; Tomohiro Kurosaki; Andrew C Chan
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

5.  Monomeric and oligomeric complexes of the B cell antigen receptor.

Authors:  W W Schamel; M Reth
Journal:  Immunity       Date:  2000-07       Impact factor: 31.745

6.  Association of SLP-65/BLNK with the B cell antigen receptor through a non-ITAM tyrosine of Ig-alpha.

Authors:  N Engels; B Wollscheid; J Wienands
Journal:  Eur J Immunol       Date:  2001-07       Impact factor: 5.532

7.  The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells.

Authors:  P J Coopman; M T Do; M Barth; E T Bowden; A J Hayes; E Basyuk; J K Blancato; P R Vezza; S W McLeskey; P H Mangeat; S C Mueller
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

8.  Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics.

Authors:  Shao-En Ong; Blagoy Blagoev; Irina Kratchmarova; Dan Bach Kristensen; Hanno Steen; Akhilesh Pandey; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2002-05       Impact factor: 5.911

9.  Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer.

Authors:  Lei Wang; Lindsay Duke; Peter S Zhang; Ralph B Arlinghaus; W Fraser Symmans; Aysegul Sahin; Richard Mendez; Jia Le Dai
Journal:  Cancer Res       Date:  2003-08-01       Impact factor: 12.701

10.  The B lymphocyte adaptor molecule of 32 kD (Bam32) regulates B cell antigen receptor signaling and cell survival.

Authors:  Hiroaki Niiro; Akito Maeda; Tomohiro Kurosaki; Edward A Clark
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

View more
  11 in total

1.  Interplay between HGAL and Grb2 proteins regulates B-cell receptor signaling.

Authors:  Xiaoyu Jiang; Xiaoqing Lu; Yu Zhang; Leda Lacaria; Brett J Schuchardt; David C Mikles; Marco Magistri; Idoia García-Ramírez; Isidro Sanchez-Garcia; Amjad Farooq; Ramiro E Verdun; Midhat H Abdulreda; Vincent T Moy; Izidore S Lossos
Journal:  Blood Adv       Date:  2019-08-13

Review 2.  Signaling mechanisms regulating B-lymphocyte activation and tolerance.

Authors:  Elias Hobeika; Peter J Nielsen; David Medgyesi
Journal:  J Mol Med (Berl)       Date:  2015-01-29       Impact factor: 4.599

Review 3.  Role of inhibitory signaling in peripheral B cell tolerance.

Authors:  Andrew Getahun
Journal:  Immunol Rev       Date:  2022-02-06       Impact factor: 12.988

4.  Unperturbed Immune Function despite Mutation of C-Terminal Tyrosines in Syk Previously Implicated in Signaling and Activity Regulation.

Authors:  Vanessa Weis; Sebastian Königsberger; Susanne Amler; Jürgen Wienands; Friedemann Kiefer
Journal:  Mol Cell Biol       Date:  2017-10-13       Impact factor: 4.272

5.  Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.

Authors:  Roland Schmitz; George W Wright; Da Wei Huang; Calvin A Johnson; James D Phelan; James Q Wang; Sandrine Roulland; Monica Kasbekar; Ryan M Young; Arthur L Shaffer; Daniel J Hodson; Wenming Xiao; Xin Yu; Yandan Yang; Hong Zhao; Weihong Xu; Xuelu Liu; Bin Zhou; Wei Du; Wing C Chan; Elaine S Jaffe; Randy D Gascoyne; Joseph M Connors; Elias Campo; Armando Lopez-Guillermo; Andreas Rosenwald; German Ott; Jan Delabie; Lisa M Rimsza; Kevin Tay Kuang Wei; Andrew D Zelenetz; John P Leonard; Nancy L Bartlett; Bao Tran; Jyoti Shetty; Yongmei Zhao; Dan R Soppet; Stefania Pittaluga; Wyndham H Wilson; Louis M Staudt
Journal:  N Engl J Med       Date:  2018-04-12       Impact factor: 91.245

6.  LynA regulates an inflammation-sensitive signaling checkpoint in macrophages.

Authors:  Tanya S Freedman; Ying X Tan; Katarzyna M Skrzypczynska; Boryana N Manz; Frances V Sjaastad; Helen S Goodridge; Clifford A Lowell; Arthur Weiss
Journal:  Elife       Date:  2015-10-30       Impact factor: 8.140

7.  Besides an ITIM/SHP-1-dependent pathway, CD22 collaborates with Grb2 and plasma membrane calcium-ATPase in an ITIM/SHP-1-independent pathway of attenuation of Ca2+i signal in B cells.

Authors:  Jie Chen; Hong Wang; Wei-Ping Xu; Si-Si Wei; Hui Joyce Li; Yun-Qing Mei; Yi-Gang Li; Yue-Peng Wang
Journal:  Oncotarget       Date:  2016-08-30

8.  Genome-wide association study meta-analysis identifies five new loci for systemic lupus erythematosus.

Authors:  Antonio Julià; Francisco Javier López-Longo; José J Pérez Venegas; Silvia Bonàs-Guarch; Àlex Olivé; José Luís Andreu; Mª Ángeles Aguirre-Zamorano; Paloma Vela; Joan M Nolla; José Luís Marenco de la Fuente; Antonio Zea; José María Pego-Reigosa; Mercedes Freire; Elvira Díez; Esther Rodríguez-Almaraz; Patricia Carreira; Ricardo Blanco; Víctor Martínez Taboada; María López-Lasanta; Mireia López Corbeto; Josep M Mercader; David Torrents; Devin Absher; Sara Marsal; Antonio Fernández-Nebro
Journal:  Arthritis Res Ther       Date:  2018-05-30       Impact factor: 5.156

Review 9.  Emerging Roles of Downstream of Kinase 3 in Cell Signaling.

Authors:  Jia Tong Loh; Joey Kay Hui Teo; Hong-Hwa Lim; Kong-Peng Lam
Journal:  Front Immunol       Date:  2020-09-29       Impact factor: 7.561

10.  A functional genomics predictive network model identifies regulators of inflammatory bowel disease.

Authors:  Lauren A Peters; Jacqueline Perrigoue; Arthur Mortha; Alina Iuga; Won-Min Song; Eric M Neiman; Sean R Llewellyn; Antonio Di Narzo; Brian A Kidd; Shannon E Telesco; Yongzhong Zhao; Aleksandar Stojmirovic; Jocelyn Sendecki; Khader Shameer; Riccardo Miotto; Bojan Losic; Hardik Shah; Eunjee Lee; Minghui Wang; Jeremiah J Faith; Andrew Kasarskis; Carrie Brodmerkel; Mark Curran; Anuk Das; Joshua R Friedman; Yoshinori Fukui; Mary Beth Humphrey; Brian M Iritani; Nicholas Sibinga; Teresa K Tarrant; Carmen Argmann; Ke Hao; Panos Roussos; Jun Zhu; Bin Zhang; Radu Dobrin; Lloyd F Mayer; Eric E Schadt
Journal:  Nat Genet       Date:  2017-09-11       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.